Brazil health regulator allows resumption of China Covid vaccine trials

Posted by on November 11, 2020 8:58 pm
Categories: Global Stories

Testing was suspended after the death of a participant, but officials say it had no relation to the trials

Brazil’s health regulator has allowed resumption of late-stage clinical trials for China’s Sinovac Covid-19 vaccine, which had been suspended due to a study subject’s death that was registered in Sao Paulo as a suicide.

The Brazilian medical institute, Butantan, said in a statement it would restart trials later on Wednesday.

Continue reading…

Leave a Reply

Your email address will not be published.